BDBM50110569 1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-piperidine-4-carboxylic acid (3-methoxy-6,7,8,9-tetrahydro-5H-benzocyclohepten-6-ylmethyl)-amide::CHEMBL167709
SMILES: COc1ccc2CCCC(CNC(=O)C3CCN(CC3)C(=O)Cn3c4cc(Cl)ccc4sc3=O)Cc2c1
InChI Key: InChIKey=SQUQYFMENMXUQP-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neuropeptide Y receptor type 5 ( NPY Y5) (Homo sapiens (Human)) | BDBM50110569 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 1.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL | Assay Description Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5 | Bioorg Med Chem Lett 12: 799-802 (2002) BindingDB Entry DOI: 10.7270/Q2M044R7 | |||||||||||
More data for this Ligand-Target Pair |